Join a leading multi-stakeholder forum on cancer #drugdiscovery in Paris.
🔗 Register now: https://ow.ly/VQce50XWy9H
#ESMOMeetings #targetedtherapies #PrecisionMedicine #ClinicalTrials
Join a leading multi-stakeholder forum on cancer #drugdiscovery in Paris.
🔗 Register now: https://ow.ly/VQce50XWy9H
#ESMOMeetings #targetedtherapies #PrecisionMedicine #ClinicalTrials
$HURA
#TuhuraBio #Bioscience #LifeSciences #Oncology #TargetedTherapies
youtube.com/shorts/eeS09...
$HURA
#TuhuraBio #Bioscience #LifeSciences #Oncology #TargetedTherapies
youtube.com/shorts/eeS09...
www.cell.com/cell-reports...
@cemm.oeaw.ac.at
@stanna-ccri.bsky.social
www.cell.com/cell-reports...
@cemm.oeaw.ac.at
@stanna-ccri.bsky.social
Explore how targeted therapies and advanced diagnostics are reshaping cancer care across Europe.
Hear from leading experts Professors Frederique Penault-Llorca and Pascal Pujol
👉 www.dxrx.io/articles/art...
#CancerCare #TargetedTherapies #Diagnostics
Explore how targeted therapies and advanced diagnostics are reshaping cancer care across Europe.
Hear from leading experts Professors Frederique Penault-Llorca and Pascal Pujol
👉 www.dxrx.io/articles/art...
#CancerCare #TargetedTherapies #Diagnostics
📆 October 22–26, 2025
📍 Hynes Convention Center, Boston, MA.
🔽 For More Information:
lnkd.in/gEWR25pd
#ADC #TargetedTherapies
📆 October 22–26, 2025
📍 Hynes Convention Center, Boston, MA.
🔽 For More Information:
lnkd.in/gEWR25pd
#ADC #TargetedTherapies
#ESMODailyReporter ➡️ https://ow.ly/IWOr50XeTfh
#LungCancer
Alfredo Addeo
#ESMODailyReporter ➡️ https://ow.ly/IWOr50XeTfh
#LungCancer
Alfredo Addeo
Showcase your research in #Cancer #DrugDiscovery & #TargetedTherapies.
Deadline: 16 December
🔗 Submit now: buff.ly/a4kXwWN
Showcase your research in #Cancer #DrugDiscovery & #TargetedTherapies.
Deadline: 16 December
🔗 Submit now: buff.ly/a4kXwWN
#BloodCancer #CancerResearch #MyelodysplasticSyndromes #AcuteMyeloidLeukemia
#BloodCancer #CancerResearch #MyelodysplasticSyndromes #AcuteMyeloidLeukemia
#ImmuneDysfunction
#ImmuneDysfunction
@astra-zeneca.bsky.social 🫁 #lungcancer #preceptorship w/ colleagues & experts including @KSamalaMD #ArthurLui 🇵🇭 together w/ #QuincyChu of @AlbertaUni 🇨🇦. Covered broad topics: #targetedtherapies, #IO, #EGFR and #SCLC. #LCSM
@cuhkmedicine.bsky.social @APCLC_2023
@astra-zeneca.bsky.social 🫁 #lungcancer #preceptorship w/ colleagues & experts including @KSamalaMD #ArthurLui 🇵🇭 together w/ #QuincyChu of @AlbertaUni 🇨🇦. Covered broad topics: #targetedtherapies, #IO, #EGFR and #SCLC. #LCSM
@cuhkmedicine.bsky.social @APCLC_2023
www.statnews.com/sponsor/2025...
www.statnews.com/sponsor/2025...
Meet: Anuja Ogirala
Research Focus: Molecular Pharmacology Program; Senior Research Assistant
synapse.mskcc.org/synapse/work...
#Neovascularization #VascularBiology #Microfluidics #OrganOnAChip #TumorModeling #CancerResearch #TargetedTherapies
Meet: Anuja Ogirala
Research Focus: Molecular Pharmacology Program; Senior Research Assistant
synapse.mskcc.org/synapse/work...
#Neovascularization #VascularBiology #Microfluidics #OrganOnAChip #TumorModeling #CancerResearch #TargetedTherapies
#LymphomaAwareness #CancerCare #Hematology #TargetedTherapies
www.marketresearchfuture.com/reports/mali...
#LymphomaAwareness #CancerCare #Hematology #TargetedTherapies
www.marketresearchfuture.com/reports/mali...
doi.org/10.1002/epi4...
#epilepsy #epilepsiaopen #ILAE #clinicaltrials #monogenicepilepsies #targetedtherapies #treatment
doi.org/10.1002/epi4...
#epilepsy #epilepsiaopen #ILAE #clinicaltrials #monogenicepilepsies #targetedtherapies #treatment
#CancerResearch #MedicalInnovation #TTT25 #BoğaziçiCT3Symposium #CT3Innovation #CT3TranslationalResearch #TumorMicroenvironment #Immunotherapy #OncologyScience #TranslationalResearch #TargetedTherapies
#CancerResearch #MedicalInnovation #TTT25 #BoğaziçiCT3Symposium #CT3Innovation #CT3TranslationalResearch #TumorMicroenvironment #Immunotherapy #OncologyScience #TranslationalResearch #TargetedTherapies
#Neoantigens #LeukemiaResearch #CancerImmunotherapy #TCellReceptors #PrecisionOncology #TumorImmunology #CancerGenomics #TargetedTherapies
#Neoantigens #LeukemiaResearch #CancerImmunotherapy #TCellReceptors #PrecisionOncology #TumorImmunology #CancerGenomics #TargetedTherapies
Laurent et al. develop a curative liver-targeted #genetherapy for lysosomal acid lipase (LAL) deficiency using a mouse model.
https://bit.ly/4iGohXa
#TargetedTherapies
Laurent et al. develop a curative liver-targeted #genetherapy for lysosomal acid lipase (LAL) deficiency using a mouse model.
https://bit.ly/4iGohXa
#TargetedTherapies
#CancerResearch #AIinHealthcare #TargetedTherapies #UCSF #AI #AIHealth #CancerCare
cancer.ucsf.edu/news/2025/04...
#CancerResearch #AIinHealthcare #TargetedTherapies #UCSF #AI #AIHealth #CancerCare
cancer.ucsf.edu/news/2025/04...
Learn about advancements and strategies to improve outcomes in this activity.
Stay informed: bit.ly/4g5DUqO
#NSCLC #TargetedTherapies #Oncology
Learn about advancements and strategies to improve outcomes in this activity.
Stay informed: bit.ly/4g5DUqO
#NSCLC #TargetedTherapies #Oncology
www.newswise.com/articles/res...
#leukemia #Lymphomas #chemotherapy #pregnancy #TargetedTherapies #immunotherapy
www.newswise.com/articles/res...
#leukemia #Lymphomas #chemotherapy #pregnancy #TargetedTherapies #immunotherapy
Umang Swami, MD, MS, University of Utah, discusses emerging #biomarkers for #targetedtherapies in patients with #metastatic hormone-sensitive #prostatecancer (mHSPC)🧪💡
👉 buff.ly/mEEvAHe
Umang Swami, MD, MS, University of Utah, discusses emerging #biomarkers for #targetedtherapies in patients with #metastatic hormone-sensitive #prostatecancer (mHSPC)🧪💡
👉 buff.ly/mEEvAHe
🔹 First-line treatment for EGFR-mutant lung cancer
🔹 Neoadjuvant, perioperative & adjuvant therapies
🔹 Emerging immunotherapy trends
🔗 Save your spot: bit.ly/BestofTTLC25
#LungCancer #Oncology #TargetedTherapies
🔹 First-line treatment for EGFR-mutant lung cancer
🔹 Neoadjuvant, perioperative & adjuvant therapies
🔹 Emerging immunotherapy trends
🔗 Save your spot: bit.ly/BestofTTLC25
#LungCancer #Oncology #TargetedTherapies